US Patent 8946163 Cross-linked collagen comprising metallic anticancer agents
Patent 8946163 was granted and assigned to MIMEDX GROUP, INC. on February, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+132 characters)
Article
Patent abstract
The disclosure describes collagen constructs comprising anticancer agents, preferably, platinum, and related methods.
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Thomas J. Koob0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08946163 Cross-linked collagen comprising metallic anticancer agents US Patent 8946163 Cross-linked collagen comprising metallic anticancer agents
Infobox
Patent Number
08946163
Patent Number
8946163
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 28 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08946163 Cross-linked collagen comprising metallic anticancer agents
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08946163
Date of patent
February 3, 2015
Patent application number
13815834
Date Filed
March 15, 2013
Patent primary examiner
Find more entities like US Patent 8946163 Cross-linked collagen comprising metallic anticancer agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
